Wegovy Nausea and Diarrhoea: What the Evidence Tells Us

What the trial data shows about these two side effects

The STEP 1 trial is the clearest window we have into how often nausea and diarrhoea occur on Wegovy. Across 68 weeks and roughly 2,000 participants, nausea appeared in about 44% of people on semaglutide 2.4 mg, against 16% on placebo. Diarrhoea followed a similar pattern: around 30% on the active treatment versus 16% on placebo. Crucially, most of these events were graded mild or moderate in severity, and the proportion of people who stopped treatment because of gastrointestinal side effects was relatively small.

The mechanism is well understood. Semaglutide slows gastric emptying, food moves through the stomach more gradually than the body is used to. That shift is partly why appetite falls, but it also explains the nausea that many people notice when they first start or increase their dose and the looser stools some people experience. The gut is adapting to a new rhythm, and for some people that adjustment also brings gas and diarrhea as the digestive system settles into its new pace. For a fuller picture of the broader side-effect profile, the Wegovy side effects overview covers the full range of reported effects beyond the gastrointestinal ones.

Dose timing matters too. Both nausea and diarrhoea tend to spike in the first week after a dose increase, then settle. The titration schedule (starting low and stepping up gradually) exists precisely because that adjustment window is predictable. It is not a sign that treatment has gone wrong; it is the body doing what the trial data said it would.

Practical steps that actually help

Clinical guidance from the NHS medicines page for semaglutide and the prescribing information both point to a handful of consistent strategies. Eating smaller, lower-fat meals reduces the load on a stomach that is already emptying more slowly than usual. Greasy or very rich foods tend to worsen nausea noticeably. Eating slowly, stopping before the old definition of full, and avoiding lying down immediately after eating all help in practical terms.

For diarrhoea specifically, staying ahead of fluid loss is the main priority, small, frequent sips of water or diluted squash rather than large volumes at once. If you store your pen in the fridge door alongside everyday items, it is a useful nudge to keep a glass of water nearby and maintain a steady hydration habit throughout the day, not just when symptoms appear.

People who find diarrhoea the more disruptive of the two symptoms may find it useful to read the more focused guidance on managing diarrhoea on Wegovy, which covers dietary adjustments in more detail. If bloating and wind accompany the loose stools, the guidance on burping and diarrhoea together on Wegovy addresses that combination directly.

When to get medical help, and what signs cannot wait

Most nausea and diarrhoea on Wegovy is unpleasant but not dangerous. Some presentations, though, need prompt attention rather than home management. Contact a GP or call 111 if diarrhoea or vomiting is severe enough that you cannot keep fluids down, lasts more than a day or two without improvement, or is accompanied by signs of dehydration such as dark urine, dizziness when standing, or confusion.

The MHRA's Drug Safety Update of January 2026 specifically flagged acute pancreatitis as a serious, though infrequent, risk with GLP-1 medicines including semaglutide. The warning sign is severe stomach pain (often constant rather than cramping, sometimes radiating toward the back) that is out of proportion to ordinary nausea. That is a reason to seek emergency care, not to wait and see. Gallbladder problems can present similarly; pain concentrated in the upper right abdomen, especially after eating, warrants assessment.

Allergic reactions are rare but possible: swelling of the face, lips or throat, difficulty breathing, or a rapid skin reaction after injection should be treated as an emergency. If you are unsure whether what you are experiencing is within the expected range or not, a call to our support team can help you decide your next step without delay.

How a prescriber fits side-effect management into ongoing care

Wegovy is a prescription-only medicine, and the prescribing relationship is not just about the first decision to start. At nume, a GPhC-registered prescriber reviews your case before each repeat, dose increases and continued supply are not automatic. That structure exists partly to assess exactly how you are tolerating each stage, including whether side effects like nausea or diarrhoea are settling as expected or suggesting something that needs clinical input.

If you are weighing whether Wegovy is the right option for you, the Wegovy treatment page sets out how the medicine works and who it is licensed for. For those considering whether to start treatment at all, the weight-loss treatments overview gives a broader picture of what is available. Suitability is a clinical judgement made with full knowledge of your health history, not a tick-box exercise. Speak to our prescribers as part of a free consultation, and side effects like these are one of the things they will address directly before any prescription is issued.